etoposide has been researched along with Injuries, Radiation in 49 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (10.20) | 18.7374 |
1990's | 11 (22.45) | 18.2507 |
2000's | 17 (34.69) | 29.6817 |
2010's | 14 (28.57) | 24.3611 |
2020's | 2 (4.08) | 2.80 |
Authors | Studies |
---|---|
Attenberger, U; Brossart, P; Garbe, S; Heine, A; Holderried, T; Kersting, L; Koch, D; Köksal, M; Leitzen, C; Sarria, GR; Scafa, D; Schmeel, LC; Schoroth, F; Zoga, E | 1 |
Adamo, V; Bottari, A; Brogna, A; Cacciola, A; Casablanca, G; Chillari, F; Ferini, G; Ferrantelli, G; Leotta, S; Lillo, S; Minutoli, F; Parisi, S; Pergolizzi, S; Platania, A; Pontoriero, A; Russo, A; Santacaterina, A; Settineri, N | 1 |
Abbassi, LM; Arsène-Henry, A; Dendale, R; Goudjil, F; Kirova, YM | 1 |
Cai, S; Shi, A; Yu, R; Zhu, G | 1 |
Batus, M; Bonomi, P; Dandekar, VK; Fidler, MJ; Kiel, K; Sher, DJ; Young, J | 1 |
Jin, JG | 1 |
Busse, PM; Ebb, DH; Friedmann, AM; Ladra, MM; Lucas, JT; MacDonald, SM; Marcus, KJ; Tarbell, NJ; Yock, TI | 1 |
Datsenko, PV; Panshin, GA | 1 |
Gomez, D; Komaki, R; Lee, MS; Levy, LB; Liao, Z; Lu, C; Tang, C; Zhuang, Y | 1 |
Chang, GJ; Crane, CH; Das, P; Feig, BW; Krishnan, S; Minsky, BD; Rashid, A; Skibber, JM; Voong, KR; Wolff, RA; Yao, JC | 1 |
Das, S; Dunphy, FR; Gu, L; Kelsey, CR; Marks, LB; Ready, NE | 1 |
Auger, J; Berthaut, I; Brugnon, F; Bujan, L; Daudin, M; Hennebicq, S; Rives, N; Saias, J; Setif, V; Szerman, E; Walschaerts, M | 1 |
Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S | 1 |
Bleyer, A; Choi, M; Fuller, CD; Raney, RB; Wang, SJ | 1 |
Atsumi, K; Hirata, H; Honda, H; Isoyama, Y; Matsuura, S; Nomoto, S; Nonoshita, T; Ohga, S; Onishi, K; Shioyama, Y; Terashima, K | 1 |
Estlin, EJ; Moulin, CJ; Pauly-Takacs, K | 1 |
Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S | 1 |
Byhardt, R; Curran, WJ; Paulus, R; Werner-Wasik, M | 1 |
Jereb, B; Macedoni-Luksic, M; Todorovski, L | 1 |
Forster, KM; Gopal, R; Kelly, JF; Komaki, R; Liao, Z; Starkschall, G; Stevens, C; Tucker, SL | 1 |
Ash, RB; Dar, AR; Stitt, LW; Truong, PT; Videtic, GM; Whiston, F; Yu, EW | 1 |
Abrey, LE; DeAngelis, LM; Lai, R; Rosenblum, MK | 1 |
Adams, PT; Ayash, LJ; Dawson, LA; Eisbruch, A; Lichter, AS; Ratanatharathorn, V; Reynolds, CM; Saito, NG; Schipper, MJ; Silver, SM; Uberti, JP | 1 |
Abelairas Gómez, JM; Calvo, JM; Olivier Pascual, N | 1 |
Sonis, ST | 1 |
Baas, P; Belderbos, JS; Burgers, JA; Kwa, HB; Senan, S; van Bochove, A; van Meerbeeck, JP; van Tinteren, H | 1 |
Bout, M; Brémond, JL; Dayan, A; Delain, M; Domenech, J; Gihana, E; Linassier, C; Petit, A; Petitdidier, C; Truglio, D | 1 |
Alexanian, R; Champlin, R; Delasalle, K; Dimopoulos, MA; Hester, J | 1 |
Ho, ES; Jan, JS; Lin, JC; Liu, FS; Yang, CH | 1 |
Hirota, S; Hishikawa, Y; Honda, K; Kono, K; Obayasi, K; Soejima, T; Takada, Y; Watanabe, H | 1 |
Fukuda, M; Hayakawa, A; Itoh, N; Kohno, S; Mori, H; Oka, M; Sakamoto, T | 1 |
Bonner, JA; Brooks, BJ; Gerstner, JB; Hillman, S; Jett, JR; Krook, JE; Levitt, R; Mailliard, JA; Maksymiuk, A; Marks, RS; Shanahan, TG; Sloan, JA; Tazelaar, HD | 1 |
Joseph, CD; Kuttan, G; Kuttan, R; Praveenkumar, V | 1 |
Bogart, JA; Chung, CT; Ryu, S; Ungureanu, C; Zamkoff, KW | 1 |
Alberto, P; Bolla, M; Bonnefoi, H; Hügli, A; Mermillod, B; Miralbell, R; Moro, D | 1 |
Alvarnas, JC; Blume, KG; Chao, NJ; Horning, SJ; Hu, WW; Long, GD; Negrin, RS; Schriber, JR; Stockerl-Goldstein, K; Tierney, K; Wong, R | 1 |
Acimovic, L; Jeremic, B; Milicic, B; Nikolic, N; Shibamoto, Y | 1 |
Ahn, YC; Han, J; Huh, SJ; Kim, DY; Kim, HJ; Kim, J; Kim, KM; Kwon, J; Lee, JE; Lee, KS; Lim, DH; Noh, YJ; Park, K; Shim, YM | 1 |
Allen, P; Cox, JD; Fossella, FV; Glisson, B; Herbst, R; Hong, WK; Kaplan, B; Kelly, JF; Khuri, F; Komaki, R; Kurie, J; Lee, JS; Liao, Z; Milas, L; Papadimitrakopoulou, V; Pisters, K; Ro, J; Stevens, CW; Thames, HD; Zinner, R | 1 |
Al-Jefri, A; Al-Mahr, M; Ayas, M; Belgaumi, A; Leung, W; Solh, H | 1 |
Fontana, JA | 1 |
Fujii, T; Hamamoto, K; Higashino, H; Iio, A; Itoh, H; Kataoka, M; Kawamura, M; Mogami, H; Nishiyama, Y | 1 |
Finlay, JL; McElwain, M; Packer, RJ; Pons, MA; Puccetti, D; Walker, RW | 1 |
Cherryman, G; Hoskin, PJ; Parton, D; Smith, IE; Yarnold, JR | 1 |
Bonomi, P; Faber, LP; Hendrickson, FR; Kittle, CF; Lee, MS; Recine, D; Reddy, S; Rowland, K; Taylor, S; Warren, W | 1 |
Collins, C; Griffin, BR; Higano, CS; Keppen, MD; Livingston, RB; Miller, TP | 1 |
Ashley, SE; Cherryman, G; Glaholm, J; Magrini, S; Repetto, L; Smith, IE; Yarnold, JR | 1 |
Glover, DJ; Mason, BA; Turrisi, AT | 1 |
Hilaris, BS; Natale, RB; Shank, B; Wittes, RE | 1 |
3 review(s) available for etoposide and Injuries, Radiation
Article | Year |
---|---|
Carboplatin and etoposide combined with radiotherapy for limited-stage small-cell esophageal carcinoma: three cases and review of the literature.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Esophageal Neoplasms; Etoposide; Female; Humans; Male; Middle Aged; Radiation Injuries | 2010 |
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cranial Irradiation; Cytarabine; Dementia; Dementia, Vascular; Demyelinating Diseases; Disease Progression; Doxorubicin; Epilepsy, Complex Partial; Etoposide; Eye Neoplasms; Fatal Outcome; Female; Gait Disorders, Neurologic; Humans; Immunocompetence; Intracranial Arteriosclerosis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Radiation Injuries; Retrospective Studies; Survival Analysis; Thiotepa; Vincristine | 2004 |
[Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Disease-Free Survival; Epirubicin; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
9 trial(s) available for etoposide and Injuries, Radiation
Article | Year |
---|---|
Phase 1 Dose Escalation Study of Accelerated Radiation Therapy With Concurrent Chemotherapy for Locally Advanced Lung Cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dose Fractionation, Radiation; Esophagus; Etoposide; Female; Heart; Humans; Lung; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Organ Sparing Treatments; Quality of Life; Radiation Injuries; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Small Cell Lung Carcinoma | 2015 |
Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prospective Studies; Radiation Injuries; Radiotherapy Dosage; Radiotherapy, Conformal; Recurrence; Statistics as Topic; Stem Cell Transplantation; Transplantation, Autologous | 2004 |
Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Double-Blind Method; Etoposide; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Mouth Mucosa; Radiation Injuries; Severity of Illness Index; Stomatitis; Treatment Outcome; Whole-Body Irradiation | 2005 |
Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Prognosis; Radiation Injuries; Survival Analysis; Treatment Outcome | 2006 |
Phase III comparison of twice-daily split-course irradiation versus once-daily irradiation for patients with limited stage small-cell lung carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Injuries; Sensitivity and Specificity; Survival Analysis | 1999 |
Myeloprotective effect of a non-toxic indigenous preparation Rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bone Marrow; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Fluorouracil; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; India; Leukocyte Count; Leukopenia; Lipid Peroxidation; Male; Mitoxantrone; Neoplasms; Pharmaceutical Preparations; Pilot Projects; Plant Extracts; Radiation Injuries; Radiotherapy | 1999 |
Phase II trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Dose Fractionation, Radiation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Injuries; Radiotherapy Dosage; Survival Rate | 2000 |
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.
Topics: Adult; Aged; Amifostine; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Esophagitis; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Injuries; Radiation Pneumonitis; Radiation-Protective Agents | 2002 |
Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Growth Disorders; Hematologic Diseases; Humans; Infant; Intellectual Disability; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Nervous System Diseases; Radiation Injuries; Remission Induction; Salvage Therapy; Treatment Outcome; Vincristine | 1992 |
37 other study(ies) available for etoposide and Injuries, Radiation
Article | Year |
---|---|
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy.
Topics: Bone Marrow; Carmustine; Etoposide; Hematologic Neoplasms; Humans; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Whole-Body Irradiation | 2023 |
Stereotactic boost on residual disease after external-beam irradiation in clinical stage III non-small cell lung cancer: mature results of stereotactic body radiation therapy post radiation therapy (SBRTpostRT) study.
Topics: Carcinoma, Non-Small-Cell Lung; Etoposide; Humans; Lung Neoplasms; Radiation Injuries; Radiosurgery; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated | 2023 |
Protontherapy versus best photon for mediastinal Hodgkin lymphoma: Dosimetry comparison and treatment using ILROG guidelines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Heart; Hodgkin Disease; Humans; Lung; Mediastinal Neoplasms; Organ Sparing Treatments; Organs at Risk; Photons; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Prednisone; Procarbazine; Proton Therapy; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Vincristine; Young Adult | 2019 |
Feasibility of omitting clinical target volume for limited-disease small cell lung cancer treated with chemotherapy and intensity-modulated radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Chemoradiotherapy, Adjuvant; Cisplatin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Small Cell Lung Carcinoma; Survival Rate; Tumor Burden | 2014 |
Efficacy and Tolerability of Palliative Split-Course Thoracic Chemoradiotherapy for Symptomatic Non-Small Cell Lung Cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Chemoradiotherapy; Chest Pain; Cohort Studies; Cough; Dyspnea; Esophagitis; Etoposide; Female; Hemoptysis; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Palliative Care; Pemetrexed; Radiation Injuries; Radiation Pneumonitis; Retrospective Studies; Treatment Outcome | 2015 |
High-dose methylprednisolone is effective in treating radiation-induced refractory haemorrhagic cystitis.
Topics: Aluminum Oxide; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Combined Modality Therapy; Cyclophosphamide; Cystitis; Doxorubicin; Estrogens; Etoposide; Fluid Therapy; Hematuria; Humans; Hyperbaric Oxygenation; Immunosuppressive Agents; Lymphatic Irradiation; Lymphatic Metastasis; Lymphoma, Mantle-Cell; Male; Methylprednisolone; Middle Aged; Prednisone; Radiation Injuries; Radiotherapy, Conformal; Recurrence; Rituximab; Salvage Therapy; Vincristine | 2014 |
Proton therapy for pediatric and adolescent esthesioneuroblastoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Humans; Kaplan-Meier Estimate; Male; Meningeal Neoplasms; Nasal Cavity; Nose Neoplasms; Proton Therapy; Radiation Injuries; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Adjuvant; Retrospective Studies; Topotecan; Treatment Outcome; Vincristine; Young Adult | 2015 |
[Hodgkin's lymphoma and radiotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy Dosage; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2015 |
Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Cisplatin; Docetaxel; Etoposide; Female; Hemoglobins; Humans; Leukopenia; Logistic Models; Lung Neoplasms; Lymphopenia; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Neutropenia; Paclitaxel; Proportional Hazards Models; Radiation Injuries; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Severity of Illness Index; Survival Rate; Taxoids; Thrombocytopenia | 2017 |
Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal.
Topics: Adult; Aged; Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Camptothecin; Capecitabine; Carboplatin; Carcinoma, Neuroendocrine; Chemoradiotherapy; Cisplatin; Consolidation Chemotherapy; Diarrhea; Digestive System Surgical Procedures; Disease-Free Survival; Etoposide; Female; Fluorouracil; Humans; Induction Chemotherapy; Irinotecan; Kaplan-Meier Estimate; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Pelvis; Radiation Injuries; Radiodermatitis; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Rectum; Retrospective Studies; Survival Rate; Tumor Burden | 2017 |
Sperm aneuploidy after testicular cancer treatment: data from a prospective multicenter study performed within the French Centre d'Étude et de Conservation des Oeufs et du Sperme network.
Topics: Adult; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Chromosomes, Human, X; Chromosomes, Human, Y; Cisplatin; Diploidy; Etoposide; France; Hospitals, University; Humans; Infertility, Male; Longitudinal Studies; Male; Prospective Studies; Radiation Injuries; Radiotherapy; Risk Factors; Semen Analysis; Spermatozoa; Testicular Neoplasms; Time Factors; Treatment Outcome; Young Adult | 2017 |
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Exercise; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine; Young Adult | 2009 |
Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Dactinomycin; Etoposide; Female; Humans; Hydrocortisone; Injections, Spinal; Male; Meninges; Methotrexate; Myelitis; Neoplasm Invasiveness; Puberty; Radiation Injuries; Retrospective Studies; Rhabdomyosarcoma; Sarcoma, Ewing; Spinal Cord; Spinal Neoplasms; Vincristine | 2009 |
SenseCam as a rehabilitation tool in a child with anterograde amnesia.
Topics: Adolescent; Amnesia, Anterograde; Antineoplastic Combined Chemotherapy Protocols; Brain Damage, Chronic; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cues; Environmental Monitoring; Etoposide; Feasibility Studies; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Image Processing, Computer-Assisted; Male; Memory, Long-Term; Memory, Short-Term; Meningeal Neoplasms; Mental Recall; Microcomputers; Neuropsychological Tests; Photography; Radiation Injuries; Recognition, Psychology; Self-Help Devices | 2011 |
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Oxygen Consumption; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy; Vinblastine; Vincristine; Young Adult | 2010 |
Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Dose Fractionation, Radiation; Esophagitis; Etoposide; Follow-Up Studies; Humans; Lung Neoplasms; Neoplasm Staging; Pneumonia; Radiation Injuries; Retrospective Studies; Survival Rate; Treatment Outcome; Vinblastine | 2011 |
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders | 2003 |
The relationship between local dose and loss of function for irradiated lung.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Etoposide; Female; Humans; Imaging, Three-Dimensional; Lung; Lung Neoplasms; Male; Middle Aged; Pulmonary Diffusing Capacity; Radiation Injuries; Radiation-Protective Agents; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Respiratory Function Tests; Retrospective Studies; Tomography, X-Ray Computed | 2003 |
Impaired diffusion capacity predicts for decreased treatment tolerance and survival in limited stage small cell lung cancer patients treated with concurrent chemoradiation.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radiation Injuries; Retrospective Studies; Risk Factors; Spirometry; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Busulfan; Carmustine; Cell Count; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoiesis; Hematopoietic Cell Growth Factors; Humans; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Multivariate Analysis; Neoplasms; Prognosis; Radiation Injuries; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1995 |
Early myeloablative therapy for multiple myeloma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Life Tables; Melphalan; Middle Aged; Multiple Myeloma; Radiation Injuries; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thiotepa; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1994 |
High complete response rate of concomitant chemoradiotherapy for locally advanced squamous cell carcinoma of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Radiation; Etoposide; Female; Fluorouracil; Humans; Middle Aged; Neoplasm Staging; Radiation Injuries; Survival Analysis; Treatment Outcome; Uterine Cervical Neoplasms | 1996 |
[Endoscopic findings of esophagitis in concurrent chemo-radiotherapy for lung cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Esophagitis; Esophagoscopy; Etoposide; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Radiation Injuries; Radiotherapy; Vindesine | 1998 |
Vasospastic angina likely related to cisplatin-containing chemotherapy and thoracic irradiation for lung cancer.
Topics: Adenocarcinoma; Aged; Angina Pectoris, Variant; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Electrocardiography; Etoposide; Heart; Humans; Lung Neoplasms; Male; Middle Aged; Myocardial Ischemia; Neoplasm Staging; Radiation Injuries; Radiotherapy; Vindesine | 1999 |
Hematologic toxic reaction to radiation therapy adjuvant to autologous peripheral blood stem cell transplantation for recurrent or refractory Hodgkin disease.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Disease Progression; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Male; Middle Aged; Neoplasm Recurrence, Local; Platelet Count; Radiation Injuries; Radiotherapy, Adjuvant; Retrospective Studies; Thrombocytopenia; Transplantation, Autologous | 2000 |
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelitis, Transverse; Neoplasm Invasiveness; Quality of Life; Radiation Injuries; Survival Analysis; Survival Rate; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2000 |
Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Dose Fractionation, Radiation; Etoposide; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Radiation Injuries; Radiotherapy; Randomized Controlled Trials as Topic; Time Factors | 2001 |
Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Esophagitis; Etoposide; Female; Hematologic Diseases; Humans; Life Tables; Lung Neoplasms; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Pneumonectomy; Preoperative Care; Prospective Studies; Radiation Injuries; Radioisotope Teletherapy; Radiotherapy, Adjuvant; Survival Analysis; Survival Rate; Treatment Outcome | 2001 |
Allogeneic BMT for infantile acute leukemia: what is the optimal conditioning regimen?
Topics: Acute Disease; Bone Marrow Transplantation; Busulfan; Cyclophosphamide; Disease-Free Survival; Etoposide; Growth Disorders; Humans; Infant; Leukemia; Radiation Injuries; Transplantation Conditioning; Transplantation, Homologous; Treatment Failure; Whole-Body Irradiation | 2002 |
Radiation recall associated with VP-16-213 therapy.
Topics: Carcinoma, Small Cell; Erythema; Etoposide; Female; Humans; Lung Neoplasms; Middle Aged; Podophyllotoxin; Radiation Injuries; Radiation-Sensitizing Agents; Time Factors | 1979 |
[A case with delayed-onset radiation pneumonitis suspected to be induced by oral etoposide].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Male; Middle Aged; Pneumonia; Radiation Injuries; Radiotherapy, High-Energy | 1992 |
Intercalated radio-chemotherapy in small cell lung cancer: toxicity and implications for future regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy Dosage | 1991 |
Combined modality therapy for locally advanced non-small cell lung carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Etoposide; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Postoperative Complications; Radiation Injuries; Radiotherapy Dosage; Survival Rate; Tomography, X-Ray Computed | 1990 |
Cyclophosphamide, vincristine, cisplatin, VP-16 and radiation therapy in extensive small-cell lung cancer. A Southwest Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Pneumonia; Radiation Injuries; Remission Induction; Thrombocytopenia; Vincristine | 1989 |
Carboplatin (JM8), etoposide (VP16) and thoracic irradiation for small cell lung cancer (S.C.L.C.): an evaluation of lung toxicity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Organoplatinum Compounds; Pneumonia; Pulmonary Fibrosis; Radiation Injuries | 1988 |
Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for the treatment of limited small cell lung cancer: a preliminary report.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Radiation Injuries; Time Factors | 1988 |
Combination cyclophosphamide, Adriamycin, and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Radiation Injuries; Vincristine | 1985 |